Search research articles
Contact Us
Filters
Showing results (161-170 of 190) with videos related to
Page
of 19
Sort By:
Nature Reviews. Neurology
|
September 3, 2024
The influence of MOGAD on diagnosis of multiple sclerosis using MRI
Ruth Geraldes, Georgina Arrambide, Brenda Banwell, et al.
Muscle & Nerve
|
February 8, 2016
Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases
Ernestina Santos, Ester Coutinho, Isabel Moreira, et al.
JAMA Neurology
|
January 7, 2018
Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Yael Hacohen, Yu Yi Wong, Christian Lechner, et al.
The Lancet. Neurology
|
April 14, 2023
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
James F Howard, Saskia Bresch, Angela Genge, et al.
JAMA Network Open
|
January 10, 2022
Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United Kingdom
Chanjira Satukijchai, Romina Mariano, Silvia Messina, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 7, 2020
International multicenter examination of MOG antibody assays
Markus Reindl, Kathrin Schanda, Mark Woodhall, et al.
The Journal of Experimental Medicine
|
February 4, 2010
Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines
Kai Kisand, Anette S Bøe Wolff, Katarina Trebusak Podkrajsek, et al.
Therapeutic Advances in Neurological Disorders
|
April 19, 2024
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study
James F Howard, Saskia Bresch, Constantine Farmakidis, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 31, 2023
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and Satralizumab
Friedemann Paul, Romain Marignier, Jacqueline Palace, et al.
Journal of Neurology
|
November 5, 2015
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes
Maciej Juryńczyk, Brian Weinshenker, Gulsen Akman-Demir, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 190) with videos related to
Sort By:
Page
of 19
Nature Reviews. Neurology
|
September 3, 2024
The influence of MOGAD on diagnosis of multiple sclerosis using MRI
Ruth Geraldes, Georgina Arrambide, Brenda Banwell, et al.
Muscle & Nerve
|
February 8, 2016
Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases
Ernestina Santos, Ester Coutinho, Isabel Moreira, et al.
JAMA Neurology
|
January 7, 2018
Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Yael Hacohen, Yu Yi Wong, Christian Lechner, et al.
The Lancet. Neurology
|
April 14, 2023
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
James F Howard, Saskia Bresch, Angela Genge, et al.
JAMA Network Open
|
January 10, 2022
Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United Kingdom
Chanjira Satukijchai, Romina Mariano, Silvia Messina, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 7, 2020
International multicenter examination of MOG antibody assays
Markus Reindl, Kathrin Schanda, Mark Woodhall, et al.
The Journal of Experimental Medicine
|
February 4, 2010
Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines
Kai Kisand, Anette S Bøe Wolff, Katarina Trebusak Podkrajsek, et al.
Therapeutic Advances in Neurological Disorders
|
April 19, 2024
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study
James F Howard, Saskia Bresch, Constantine Farmakidis, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 31, 2023
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and Satralizumab
Friedemann Paul, Romain Marignier, Jacqueline Palace, et al.
Journal of Neurology
|
November 5, 2015
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes
Maciej Juryńczyk, Brian Weinshenker, Gulsen Akman-Demir, et al.
Page
of 19